Journal Article

Disseminated Gonococcal Infection Associated with Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria: A Case Report and Literature Review

Morioka, Masanobu, Harada, Shinpei, Mori, Akio, Izumiyama, Koh, Saito, Makoto, Ogasawara, Reiki, Kondo, Takeshi

2020

Overview

Eculizumab has been developed as a breakthrough treatment for paroxysmal nocturnal hemoglobinuria (PNH). Not only for breakthroughs, eculizumab therapy is also known to increase the risk of invasive meningococcal infection. It has also been recently reported that, although rarely, administration of eculizumab may result in disseminated gonococcal infection (DGI). We report here a case in which a young patient who had used eculizumab for PNH developed DGI. A 22-year-old Japanese male with PNH who had been treated with eculizumab complained of high fever, mild nausea, headache and right knee joint pain. The patient was admitted and suspected to have sepsis due to meningococcal infection and began to receive ceftriaxone (CTRX). Gonococci were detected in a venous blood culture a few days later, and this case was diagnosed as DGI. CTRX was effective, and the patient was discharged. However, four weeks later, he complained of the same subjective symptoms as at the beginning and was hospitalized again. The presence of gonococcus was proven by venous blood culture, CTRX was re-administered and the patient responded. After discharge, he was counseled on safer sexual activity, including accurate and consistent use of condoms, by urologists. He has not relapsed with DGI for more than one year. When serious signs of infection occur in patients receiving eculizumab, it is recommended to consider DGI as well as invasive meningococcal infection, and CTRX should be given. Keywords: disseminated gonococcal infection, DGI, eculizumab, paroxysmal nocturnal hemoglobinuria, PNH, ceftriaxone

• Publisher: Dove Medical Press Limited,Taylor & Francis Ltd,Dove Press,Dove,Dove Medical Press
• Subject: Anemia / Antibiotics / Blood / Blood tests / Care and treatment / Case Report / Case reports / ceftriaxone / DGI / Disease / Disease prevention / disseminated gonococcal infection / disseminated gonococcal infection (dgi) / Drug dosages / Eculizumab / Health aspects / Infection / Infections / Laboratories / Meningitis / Monoclonal antibodies / Neutrophils / Pain / paroxysmal nocturnal hemoglobinuria / paroxysmal nocturnal hemoglobinuria (pnh) / Patients / PNH / Thrombosis / Vaccines